Page 4 - Tarsu Form News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tarsus Pharmaceuticals (TARS) Announces Board Transition Plans

Tarsus Pharmaceuticals (TARS) Announces Board Transition Plans
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Michael ackermannDavid nakasoneAdrienne kempBobak azamianWendy yarnoTarsus coTarsus pharmaceuticals incExchange commissionUs food drug administrationCorporate communicationsStanford byers centerTarsus co founderLead independent directorTarsus pharmaceuticalsNew drug applicationDrug administration

Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings

Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesElizabeth yeuDemodex blepharitisblepharitisAdrienne kempsrLisa nijmTarsus pharmaceuticals incDrug administrationAmerican academy of ophthalmologyExchange commissionWorld cornea congressCorporate communicationsAmerican academyChief medical advisorNew drug applicationObservational safety trialLong term safety

Tarsus Initiates Phase 2a Ersa Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease

Tarsus Initiates Phase 2a Ersa Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDemodex blepharitisblepharitisAdrienne kempsrExchange commissionCorporate communicationsTarsus pharmaceuticals incDrug administrationWall streetMeibomian gland diseaseNew drug applicationChief medical officerDry eye diseaseTarsus pharmaceuticalsInc tarsus pharmaceuticalsMeibomian glandLooking statementsstatements

Tarsus Appoints Elizabeth Yeu, M D , a Nationally Recognized Ophthalmologist and Eye Care Leader, to its Board of Directors

Tarsus Appoints Elizabeth Yeu, M D , a Nationally Recognized Ophthalmologist and Eye Care Leader, to its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eastern virginia medical schoolUnited statesRush university medical centerElizabeth yeuDavid nakasoneBobak azamianVirginia surgery centerTarsus pharmaceuticals incVirginia eye foundationExchange commissionAmerican society of cataractNetwork for the american academy of ophthalmologyCommittee memberCullen eye instituteTechnology committeeUniversity of florida college medicine

Tarsus Pharmaceuticals, Inc Presents Data from Two Pioneering Studies on the Prevalence and

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesDavid nakasoneBobak azamianExchange commissionAmerican academy of optometry aaoptTarsus pharmaceuticals incDrug administrationKentucky college of optometryAmerican academyChief executive officerPaul karpeckiCornea servicesKentucky eye instituteAssociate professorKentucky collegeTarsus pharmaceuticals